Open access

LIMITED IMPACT OF TREATMENT AND RE-TREATMENT WITH ARTEMETHER-LUMEFANTRINE AND ARTESUNATE-AMODIAQUINE ON THE SELECTION OF PLASMODIUM FALCIPARUM MULTIDRUG RESISTANCE-1 ALLELES
Vito Baraka, Carolyn Nabasumba, Filbert Francis, Pascal Lutumba, Hypolite Mavoko, Michael Alifrangis, Jean-Pierre Van Geertruyden

BMJ Global Health Feb 2017, 2 (Suppl 2) A18; DOI: 10.1136/bmjgh-2016-000260.44
EFFICACY AND TOLERABILITY OF REPEATED ADMINISTRATION OF ACTS OVER A PERIOD OF TWO YEARS IN CHILDREN AND ADULT PATIENTS WITH ACUTE UNCOMPLICATED MALARIA IN BURKINA FASO
Issiaka Soulama, Moïse Kaboré, Aboubacar Coulibaly, Maurice Ouattara, Souleymane Sanon, Amidou Diarra, Edith Bougouma, Alphonse Ouedraogo, Benjamin Sombie, Amidou Ouedraogo, Désiré Kargougou, Daouda Ouattara, Nebie Issa, Alfred Tiono, Sodiomon Sirima

BMJ Global Health Feb 2017, 2 (Suppl 2) A19-A20; DOI: 10.1136/bmjgh-2016-000260.48
VARIABILITY IN CLINICAL RESEARCH DATA MANAGEMENT PRACTICES: LESSONS FROM THE MALARIA COMMUNITY
Amélie Julé, Hazel Ashurst, Laura Merson, Piero Olliaro, Vicki Marsh, Trudie Lang, Philippe Guérin

BMJ Global Health Feb 2017, 2 (Suppl 2) A19; DOI: 10.1136/bmjgh-2016-000260.46
THE QUEST FOR BUILDING LABORATORY CAPACITY TO SUPPORT CONTROLLED HUMAN MALARIA INFECTION (CHMI) STUDIES IN SUB-SAHARAN AFRICA: EXPERIENCE WITH FIVE SITES
Kennedy Awuondo, Daniel Njenga, Elizabeth Nyakarungu, Pauline Titus, Awalludin Sutamihardja, Brett Lowe, Bernhards Ogutu, Peter Billingsley

BMJ Global Health Feb 2017, 2 (Suppl 2) A19; DOI: 10.1136/bmjgh-2016-000260.47
EFFICACY AND SAFETY OF ARTEMISININ-BASED COMBINATION THERAPIES IN PEOPLE WITH PLASMODIUM FALCIPARUM MALARIA RECEIVING ANTIRETROVIRAL THERAPY IN ZAMBIA
Mike Chaponda

BMJ Global Health Feb 2017, 2 (Suppl 2) A20; DOI: 10.1136/bmjgh-2016-000260.49
GAMETOCYTE CARRIAGE AFTER A TREATMENT WITH PRIMAQUINE COMBINED WITH DIHYDROARTEMISININ-PIPERAQUINE IN MALARIA-INFECTED, ASYMPTOMATIC INDIVIDUALS
Edgard Dabira

BMJ Global Health Feb 2017, 2 (Suppl 2) A20; DOI: 10.1136/bmjgh-2016-000260.50
COMPARISON OF AUTOMATIC AND MANUAL MEASUREMENT OF QT AND QTC INTERVALS DURING A CLINICAL PHASE III-B/ IV IN KOLLE, MALI
François Dao, Nianwalou Dara, Bouran Sidibe, Moctar Coulibaly, Allaye Tolo, Hamma Maiga, Nouhoum Ouologuem, Hamidou Niangaly, Issaka Sagara, Abdoulaye Djimde

BMJ Global Health Feb 2017, 2 (Suppl 2) A20-A21; DOI: 10.1136/bmjgh-2016-000260.51
GENE VARIATION AND SUSPECTED PLASMODIUM FALCIPARUM HISTIDINE-RICH PROTEIN 2 GENE DELETION AND ITS IMPACT ON SENSITIVITY OF MALARIA RAPID DIAGNOSTIC TESTS IN SUDAN
Muzamil Abdel Hamid, Mona Awad-Elgeid, Awad Nasr

BMJ Global Health Feb 2017, 2 (Suppl 2) A21; DOI: 10.1136/bmjgh-2016-000260.53
RE-EVALUATION OF MALARIA DIAGNOSIS BY MOLECULAR METHODS REVEALS MUTATIONS IN HRP-2 AND DRUG RESISTANCE MARKERS IN CAMEROON
Palmer Netongo, Séverin Kamdem, Thirumalaisamy Velavan, Peter Kremsner

BMJ Global Health Feb 2017, 2 (Suppl 2) A21-A22; DOI: 10.1136/bmjgh-2016-000260.54
CXCL10 GENE PROMOTER POLYMORPHISM – 1447A>G IS ASSOCIATED WITH MALARIA IN GHANAIAN CHILDREN
Felix Botchway, Nana Wilson, Carmen M Dickinson-Copeland, Andrew A. Adjei, Michael Wilson, Jonathan K. Stiles

BMJ Global Health Feb 2017, 2 (Suppl 2) A21; DOI: 10.1136/bmjgh-2016-000260.52

Main menu

Open access

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Open access

Pages